# EDGAR Filing Document

**Accession Number:** 0001039803
**File Stem:** 0000910472-26-001834
**Filing Date:** 2026-2
**Character Count:** 25645
**Document Hash:** f766bae0bfa230f703e13a00f44a463b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000910472-26-001834.hdr.sgml**: 20260219

**ACCESSION NUMBER**: 0000910472-26-001834

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260219

**DATE AS OF CHANGE**: 20260219

**PERIOD START**: 20251231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ProFunds
- **CENTRAL INDEX KEY:** 0001039803

**ORGANIZATION NAME:**
- **EIN:** 522035197
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08239
- **FILM NUMBER:** 26652703

**BUSINESS ADDRESS:**
- **STREET 1:** 7272 WISCONSIN AVENUE
- **STREET 2:** 21ST FLOOR
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20814
- **BUSINESS PHONE:** 2404976428

**MAIL ADDRESS:**
- **STREET 1:** 7272 WISCONSIN AVENUE
- **STREET 2:** 21ST FLOOR
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20814

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROFUNDS
- **DATE OF NAME CHANGE:** 19970521

## Series and Classes Contracts Data

### PROFUND VP PHARMACEUTICALS (Series ID: S000003975)

| Class ID   | Class Name                 | Ticker Symbol   |
|:---|:---|:---|
| C000011102 | PROFUND VP PHARMACEUTICALS |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ProFunds

- **b. Investment Company Act file number:** 811-08239

- **c. CIK number of Registrant:** 0001039803

- **d. LEI of Registrant:** 549300HM4OOUYSE5DP77

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 7272 Wisconsin Avenue

  - **City:** Bethesda

  - **State:** MD

  - **Foreign country:** US

  - **Zip / Postal Code:** 20814

  - **Telephone number:** 240-497-6400

**Item A.2. Information about the Series.**

- **a. Name of Series:** PROFUND VP PHARMACEUTICALS

- **b. EDGAR series identifier (if any):** S000003975

- **c. LEI of Series:** 0NO8WMNO78H6WEYS4K25

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-12-31

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $11488072.49

**Total Liabilities:** $998370.30

**Net Assets:** $10489702.19

**Cash Not Reported:** $80150.80

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000011102 | 3.51%                | 9.96%                | 2.59%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-78113.86               | $434896.26                                 |
| Month 2  | $9460.20                 | $896197.34                                 |
| Month 3  | $1131295.60              | $-874750.16                                |

**Designated Index Information**

- **Index Name:** Dow Jones U.S. Select Pharmaceuticals Index

- **Index Identifier:** DJSPHM

### Schedule of Portfolio Investments

| Name                                | Title                                         | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ANI Pharmaceuticals Inc.            | ANI Pharmaceuticals, Inc.                     | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |      2313 | NS      | $182588.22    | 1.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Alumis Inc                          | Alumis, Inc.                                  | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3341 | NS      | $32608.16     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Amneal Pharmaceuticals Inc          | Amneal Pharmaceuticals, Inc.                  | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |     15536 | NS      | $195753.60    | 1.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc       | Amphastar Pharmaceuticals, Inc.               | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |      6233 | NS      | $166919.74    | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Amylyx Pharmaceuticals Inc          | Amylyx Pharmaceuticals, Inc.                  | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14339 | NS      | $173215.12    | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Aquestive Therapeutics Inc          | Aquestive Therapeutics, Inc.                  | CUSIP: 03843E104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20630 | NS      | $133269.80    | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                         | Arvinas, Inc.                                 | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14321 | NS      | $169847.06    | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc.            | Axsome Therapeutics, Inc.                     | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |      1271 | NS      | $232135.44    | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                 | VPPH_SPSIPH_GOLDMAN                           | CUSIP: N/A<br>LEI: N/A                        | Long             | DE               |  | US        |        94 | OU      | $-9845.49     | -0.09%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | VPPH_SPSIPH_GOLDMAN                           | CUSIP: N/A<br>LEI: N/A                        | Short            | DE               |  | US        |       -57 | OU      | $6012.39      | 0.06%             |  |  |  | No            |                  2 | On Loan: No      |
| Bristol-Myers Squibb Company        | Bristol-Myers Squibb Company                  | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |      3704 | NS      | $199793.76    | 1.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc.       | Collegium Pharmaceutical, Inc.                | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |      3883 | NS      | $179782.90    | 1.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc.           | Corcept Therapeutics, Inc.                    | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |      2224 | NS      | $77395.20     | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| CorMedix Inc.                       | CorMedix, Inc.                                | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |     14413 | NS      | $167623.19    | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc.      | Crinetics Pharmaceuticals, Inc.               | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |      3947 | NS      | $183732.85    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc.          | Edgewise Therapeutics, Inc.                   | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7991 | NS      | $198296.67    | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc            | Elanco Animal Health, Inc.                    | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |      8906 | NS      | $201542.78    | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc            | Enliven Therapeutics, Inc.                    | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7155 | NS      | $110187.00    | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Esperion Therapeutics Inc           | Esperion Therapeutics, Inc.                   | CUSIP: 29664W105<br>LEI: 549300OFU56UKEWVUS92 | Long             | EC               | CORP              | US        |     49530 | NS      | $183261.00    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                          | Evolus, Inc.                                  | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |     14752 | NS      | $98100.80     | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Eyepoint Inc.                       | EyePoint Pharmaceuticals, Inc.                | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     11346 | NS      | $207291.42    | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings Inc    | Harmony Biosciences Holdings, Inc.            | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4831 | NS      | $180776.02    | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Harrow Inc                          | Harrow, Inc.                                  | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3779 | NS      | $185171.00    | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                        | Innoviva, Inc.                                | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |      9200 | NS      | $183908.00    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                   | Johnson & Johnson                             | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |       918 | NS      | $189980.10    | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Zevra Therapeutics Inc              | Zevra Therapeutics, Inc.                      | CUSIP: 488445206<br>LEI: 254900CU6T74V18Y1W18 | Long             | EC               | CORP              | US        |     12917 | NS      | $115736.32    | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Lenz Therapeutics Inc               | LENZ Therapeutics, Inc.                       | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6140 | NS      | $98240.00     | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Incorporated | Ligand Pharmaceuticals, Inc.                  | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      1031 | NS      | $194931.17    | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                     | Eli Lilly & Company                           | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       191 | NS      | $205263.88    | 1.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corporation                | Liquidia Corporation                          | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |      5805 | NS      | $200214.45    | 1.91%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences, Inc.               | MBX Biosciences, Inc.                         | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6582 | NS      | $207596.28    | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Maze Therapeutics Inc               | Maze Therapeutics, Inc.                       | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4255 | NS      | $176284.65    | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co., Inc                    | Merck & Company, Inc.                         | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |      1943 | NS      | $204520.18    | 1.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine (MindMed) Inc.        | Mind Medicine MindMed, Inc.                   | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | US        |     15323 | NS      | $205174.97    | 1.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                 | Nektar Therapeutics                           | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |      3285 | NS      | $138889.80    | 1.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                    | Nuvation Bio, Inc.                            | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24196 | NS      | $216796.16    | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocular Therapeutix Inc              | Ocular Therapeutix, Inc.                      | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |     12310 | NS      | $149443.40    | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Omeros Corp                         | Omeros Corporation                            | CUSIP: 682143102<br>LEI: 549300CJWLXX2MXVVV71 | Long             | EC               | CORP              | US        |      9920 | NS      | $170376.00    | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                        | Organon & Company                             | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |     26421 | NS      | $189438.57    | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira Biosciences Inc              | Pacira BioSciences, Inc.                      | CUSIP: 695127100<br>LEI: 549300P56LERYBDHCF69 | Long             | EC               | CORP              | US        |      7534 | NS      | $194979.92    | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc.                         | Pfizer, Inc.                                  | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |      7358 | NS      | $183214.20    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Phathom Pharmaceuticals Inc         | Phathom Pharmaceuticals, Inc.                 | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11241 | NS      | $186488.19    | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corporation    | Phibro Animal Health Corporation              | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |      4413 | NS      | $164869.68    | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc    | Prestige Consumer Healthcare, Inc.            | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3092 | NS      | $190745.48    | 1.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapport Therapeutics Inc            | Rapport Therapeutics, Inc.                    | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6329 | NS      | $192021.86    | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Septerna Inc.                       | Septerna, Inc.                                | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3422 | NS      | $95405.36     | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals, Inc       | Supernus Pharmaceuticals, Inc.                | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |      4110 | NS      | $204267.00    | 1.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc          | Tarsus Pharmaceuticals, Inc.                  | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2333 | NS      | $191026.04    | 1.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Terns Pharmaceuticals Inc.          | Terns Pharmaceuticals, Inc.                   | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |      4252 | NS      | $171780.80    | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc              | Trevi Therapeutics, Inc.                      | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13387 | NS      | $167605.24    | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventyx Biosciences Inc.             | Ventyx Biosciences Inc                        | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11065 | NS      | $99916.95     | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                         | Viatris, Inc.                                 | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |     16353 | NS      | $203594.85    | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc        | Xeris Biopharma Holdings, Inc.                | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     27334 | NS      | $214571.90    | 2.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc.                         | Zoetis, Inc.                                  | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |      1607 | NS      | $202192.74    | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC          | Avadel Pharmaceuticals plc                    | CUSIP: G29687103<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |      8831 | NS      | $190308.05    | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Indivior PLC                        | Indivior plc                                  | CUSIP: G4766E116<br>LEI: 213800V3NCQTY7IED471 | Long             | EC               | CORP              | GB        |      5351 | NS      | $191993.88    | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC            | Jazz Pharmaceuticals plc                      | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |      1150 | NS      | $195500.00    | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                  | Royalty Pharma plc                            | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | US        |      4958 | NS      | $191577.12    | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc            | Theravance Biopharma, Inc.                    | CUSIP: G8807B106<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |      4629 | NS      | $86608.59     | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Company PLC                 | Perrigo Company plc                           | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |     14031 | NS      | $195311.52    | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                 | HSBC SECURITIES (USA), INC.  3.65 , 1/02/2025 | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |     35000 | PA      | $35000.00     | 0.33%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | NATWEST MARKETS PLC  3.72 , 1/02/2025         | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |     65000 | PA      | $65000.00     | 0.62%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | ROYAL BANK OF CANADA  3.54 , 1/02/2025        | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |     35000 | PA      | $35000.00     | 0.33%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | SOCIETE' GENERALE  3.66 , 1/02/2025           | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |     83000 | PA      | $83000.00     | 0.79%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | UMB FINANCIAL CORP.  3.49 , 1/02/2025         | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |     33000 | PA      | $33000.00     | 0.31%             |  |  |  | No            |                  2 | On Loan: No      |
| Wave Life Sciences Ltd.             | WaVe Life Sciences Ltd.                       | CUSIP: Y95308105<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | US        |      9377 | NS      | $159409.00    | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-12-31

**Name of Applicant:** ProFund VP Pharmaceuticals

**Signature:** Rebecca Colvin

**Name of Signer:** Rebecca Colvin

**Title:** Treasurer and Principal Financial Officer